{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:17:20Z","timestamp":1788351440214,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019974","name":"Nanning Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tiv.2026.106279","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:08:00Z","timestamp":1784732880000},"page":"106279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microbiota-derived Indole-3-propionic acid improves FFA-induced liver injury in an in vitro model of nonalcoholic fatty liver disease by activating PINK1\/parkin-mediated mitophagy"],"prefix":"10.1016","volume":"117","author":[{"given":"Qilin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengyang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tiv.2026.106279_bb0005","first-page":"339","article-title":"Gut microbiota and non-alcoholic fatty liver disease","volume":"67","author":"Abenavoli","year":"2021","journal-title":"Minerva Gastroenterol (Torino)"},{"issue":"4","key":"10.1016\/j.tiv.2026.106279_bb0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/13813455.2017.1398262","article-title":"The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour","volume":"124","author":"Abildgaard","year":"2018","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.tiv.2026.106279_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109414","article-title":"Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy","volume":"120","author":"Cao","year":"2023","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.tiv.2026.106279_bb0020","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41401-025-01495-w","article-title":"Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism","volume":"46","author":"Cheng","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tiv.2026.106279_bb0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.acc.2019.08.005","article-title":"Tryptophan in health and disease","volume":"95","author":"Comai","year":"2020","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.tiv.2026.106279_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/srep46337","article-title":"Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish diabetes prevention study","volume":"7","author":"de Mello","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106279_bb0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.phrs.2019.01.029","article-title":"Interactions between gut microbiota and non-alcoholic liver disease: the role of microbiota-derived metabolites","volume":"141","author":"Ding","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tiv.2026.106279_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","article-title":"PINK1\/parkin-mediated mitophagy in mammalian cells","volume":"33","author":"Eiyama","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"2","key":"10.1016\/j.tiv.2026.106279_bb0050","article-title":"WAC facilitates mitophagy-mediated MSC osteogenesis and new bone formation via protecting PINK1 from ubiquitination-dependent degradation","volume":"12","author":"Fan","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.tiv.2026.106279_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"14","key":"10.1016\/j.tiv.2026.106279_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147735","article-title":"Limosilactobacillus reuteri attenuates atopic dermatitis via changes in gut bacteria and indole derivatives from tryptophan metabolism","volume":"23","author":"Fang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7896","key":"10.1016\/j.tiv.2026.106279_bb0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41586-021-04340-2","article-title":"Activation mechanism of PINK1","volume":"602","author":"Gan","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.tiv.2026.106279_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/13813455.2021.2024577","article-title":"Indole-3-propionic acid attenuates high glucose induced ER stress response and augments mitochondrial function by modulating PERK-IRE1-ATF4-CHOP signalling in experimental diabetic neuropathy","volume":"130","author":"Gundu","year":"2024","journal-title":"Arch. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.tiv.2026.106279_bb0075","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1021\/acs.jafc.4c08548","article-title":"Indole-3-propionic acid attenuates neuroinflammation and cognitive deficits by inhibiting the RAGE-JAK2-STAT3 signaling pathway","volume":"73","author":"Hao","year":"2025","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.tiv.2026.106279_bb0080","first-page":"253","article-title":"PINK1\/Park2-mediated mitophagy relieve non-alcoholic fatty liver disease","volume":"73","author":"He","year":"2024","journal-title":"Physiol. Res."},{"issue":"1","key":"10.1016\/j.tiv.2026.106279_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/joim.12892","article-title":"Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation","volume":"286","author":"Hendrikx","year":"2019","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.tiv.2026.106279_bb0090","doi-asserted-by":"crossref","first-page":"858","DOI":"10.14336\/AD.2022.0916","article-title":"Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies","volume":"14","author":"Huang","year":"2023","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.tiv.2026.106279_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06266-z","article-title":"Indole-3-propionic acid promotes hepatic stellate cells inactivation","volume":"23","author":"Ilha","year":"2025","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.tiv.2026.106279_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13178","article-title":"Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo","volume":"30","author":"Jennis","year":"2018","journal-title":"Neurogastroenterol. Motil."},{"issue":"8","key":"10.1016\/j.tiv.2026.106279_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081712","article-title":"Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD)","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.tiv.2026.106279_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.tiv.2026.106279_bb0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/15548627.2024.2429371","article-title":"USP4 depletion-driven RAB7A ubiquitylation impairs autophagosome-lysosome fusion and aggravates periodontitis","volume":"21","author":"Kang","year":"2025","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.tiv.2026.106279_bb0120","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","article-title":"Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis","volume":"35","author":"Kuang","year":"2023","journal-title":"Cell Metab."},{"issue":"15","key":"10.1016\/j.tiv.2026.106279_bb0125","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/bph.15083","article-title":"Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.tiv.2026.106279_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00313-20","article-title":"The gut microbiota-produced indole-3-propionic acid confers the antihyperlipidemic effect of mulberry-derived 1-deoxynojirimycin","volume":"5","author":"Li","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.tiv.2026.106279_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101817","article-title":"PINK1\/parkin-mediated mitophagy in neurodegenerative diseases","volume":"84","author":"Li","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.tiv.2026.106279_bb0140","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7150\/thno.79876","article-title":"Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation","volume":"13","author":"Lu","year":"2023","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.tiv.2026.106279_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040837","article-title":"Role and mechanisms of mitophagy in liver diseases","volume":"9","author":"Ma","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.tiv.2026.106279_bb0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med. (Lond.)"},{"issue":"5","key":"10.1016\/j.tiv.2026.106279_bb0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","article-title":"Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.tiv.2026.106279_bb0160","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"issue":"49","key":"10.1016\/j.tiv.2026.106279_bb0165","doi-asserted-by":"crossref","first-page":"74377","DOI":"10.1007\/s11356-022-21075-3","article-title":"3-Indolepropionic acid prevented chlorpyrifos-induced hepatorenal toxicities in rats by improving anti-inflammatory, antioxidant, and pro-apoptotic responses and abating DNA damage","volume":"29","author":"Owumi","year":"2022","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.tiv.2026.106279_bb0170","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"10.1016\/j.tiv.2026.106279_bb0175","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/nu13103509","article-title":"Indole-3-propionic acid, a gut-derived tryptophan metabolite, associates with hepatic fibrosis","volume":"13","author":"Sehgal","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.tiv.2026.106279_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70013","article-title":"Protein ubiquitination modification in pulmonary fibrosis","volume":"15","author":"Shen","year":"2025","journal-title":"Compr. Physiol."},{"issue":"7\u20139","key":"10.1016\/j.tiv.2026.106279_bb0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/ars.2022.0114","article-title":"The role and mechanism of action of mitophagy in various liver diseases","volume":"38","author":"Wang","year":"2023","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tiv.2026.106279_bb0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2022.05.025","article-title":"PINK1\/parkin-mediated mitophagy in cardiovascular disease: from pathogenesis to novel therapy","volume":"361","author":"Wu","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.tiv.2026.106279_bb0195","article-title":"The mechanism underlying the influence of Indole-3-propionic acid: a relevance to metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7\u20139","key":"10.1016\/j.tiv.2026.106279_bb0200","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/ars.2022.0194","article-title":"Selenium ameliorated oxidized fish oil-induced lipotoxicity via the inhibition of mitochondrial oxidative stress, Remodeling of Usp4-mediated Deubiquitination, and stabilization of Ppar\u03b1","volume":"40","author":"Zhang","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tiv.2026.106279_bb0205","article-title":"The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver disease","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tiv.2026.106279_bb0210","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/hep.29889","article-title":"Ubiquitin-specific protease 4 is an endogenous negative regulator of metabolic dysfunctions in nonalcoholic fatty liver disease in mice","volume":"68","author":"Zhao","year":"2018","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.tiv.2026.106279_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.tiv.2026.106279_bb0220","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04367-1","article-title":"Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy","volume":"21","author":"Zheng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tiv.2026.106279_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101120","article-title":"Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing parkin-related mitophagy","volume":"21","author":"Zhou","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2026.106279_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121162","article-title":"Mechanism and regulation of mitophagy in nonalcoholic fatty liver disease (NAFLD): a mini-review","volume":"312","author":"Zhu","year":"2023","journal-title":"Life Sci."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:35:21Z","timestamp":1788348921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233326000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"alternative-id":["S0887233326000871"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106279","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota-derived Indole-3-propionic acid improves FFA-induced liver injury in an in vitro model of nonalcoholic fatty liver disease by activating PINK1\/parkin-mediated mitophagy","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106279"}}